Phase 1 dose escalation multicenter trial of pracinostat alone and in combination with azacitidine in patients with advanced hematologic malignancies
Yasmin M. Abaza, Tapan M. Kadia, Elias J. Jabbour, Marina Y. Konopleva, Gautam Borthakur, Alessandra Ferrajoli, Zeev Estrov, William G. Wierda, Ana Alfonso, Toh Han Chong, Charles Chuah, Liang Piu Koh, Boon Cher Goh, Julie E. Chang, Daniel E. Durkes, Maria Cielo Foudray, Hagop M. Kantarjian, Xiao Qin Dong, Guillermo Garcia-Manero*
Dive into the research topics of 'Phase 1 dose escalation multicenter trial of pracinostat alone and in combination with azacitidine in patients with advanced hematologic malignancies'. Together they form a unique fingerprint.